Angie D. Fulford

1.4k total citations
14 papers, 494 citations indexed

About

Angie D. Fulford is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Angie D. Fulford has authored 14 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Angie D. Fulford's work include Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Celiac Disease Research and Management (2 papers). Angie D. Fulford is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Celiac Disease Research and Management (2 papers). Angie D. Fulford collaborates with scholars based in United States. Angie D. Fulford's co-authors include Robert V. Considine, James Hollis, Bridget A. Cassady, Richard D. Mattes, RoseMarie Jones, Munro Peacock, Brenda Cacucci, Timothy R. Holzer, Andrew E. Schade and Susan M. Perkins and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Angie D. Fulford

14 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angie D. Fulford United States 7 141 131 124 92 87 14 494
Birgit Hoeft Germany 12 110 0.8× 105 0.8× 55 0.4× 47 0.5× 123 1.4× 17 610
Mukadder Serter Türkiye 12 60 0.4× 76 0.6× 56 0.5× 43 0.5× 54 0.6× 29 620
Giovanna Di Bella Italy 9 136 1.0× 146 1.1× 36 0.3× 17 0.2× 183 2.1× 13 519
Kari Savolainen Finland 12 144 1.0× 175 1.3× 50 0.4× 63 0.7× 56 0.6× 20 509
GM Wardlaw United States 8 254 1.8× 195 1.5× 119 1.0× 67 0.7× 151 1.7× 8 625
Jennifer C. Gilman United States 11 98 0.7× 241 1.8× 37 0.3× 109 1.2× 70 0.8× 12 498
Ingrid M.F. Gjelstad Norway 15 141 1.0× 309 2.4× 38 0.3× 86 0.9× 171 2.0× 22 602
Milly Ryan-Harshman United Kingdom 11 131 0.9× 58 0.4× 66 0.5× 30 0.3× 75 0.9× 15 373
S. Güler Türkiye 14 101 0.7× 81 0.6× 43 0.3× 36 0.4× 64 0.7× 33 558
Greg C. Smith Australia 15 83 0.6× 225 1.7× 54 0.4× 15 0.2× 55 0.6× 25 595

Countries citing papers authored by Angie D. Fulford

Since Specialization
Citations

This map shows the geographic impact of Angie D. Fulford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angie D. Fulford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angie D. Fulford more than expected).

Fields of papers citing papers by Angie D. Fulford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angie D. Fulford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angie D. Fulford. The network helps show where Angie D. Fulford may publish in the future.

Co-authorship network of co-authors of Angie D. Fulford

This figure shows the co-authorship network connecting the top 25 collaborators of Angie D. Fulford. A scholar is included among the top collaborators of Angie D. Fulford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angie D. Fulford. Angie D. Fulford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Griffin, Michael J., Aaron M. Gruver, Chintan Shah, et al.. (2023). Tu1352 FULLY AUTOMATED HISTOLOGICAL CLASSIFICATION OF CELL TYPES AND TISSUE REGIONS OF CELIAC DISEASE IS FEASIBLE AND CORRELATES WITH THE MARSH SCORE. Gastroenterology. 164(6). S–1027. 1 indexed citations
3.
Nasir, Aejaz, Beverly L. Falcón, Dan Wang, et al.. (2018). Vascular and tumor cell expression of VEGFR2 and molecular subtyping: An innovative biomarker approach in bladder cancer.. Journal of Clinical Oncology. 36(6_suppl). 497–497. 1 indexed citations
4.
Holzer, Timothy R., Angie D. Fulford, Xuekui Zhang, et al.. (2016). Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.. PubMed. 36(7). 3277–88. 6 indexed citations
5.
Nasir, Aejaz, Angie D. Fulford, Mark Uhlik, et al.. (2016). Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.. PubMed. 36(6). 2683–96. 14 indexed citations
6.
Holzer, Timothy R., et al.. (2015). Abstract 4157: Heterogeneity of vascular endothelial growth factor receptors 1, 2, and 3 in human non-small cell lung carcinomas. Cancer Research. 75(15_Supplement). 4157–4157. 1 indexed citations
7.
Holzer, Timothy R., Angie D. Fulford, Beverly L. Falcón, et al.. (2014). Abstract 3007: Heterogeneity of vascular endothelial growth factor receptors 1, 2, and 3 in primary human colorectal adenocarcinoma. Cancer Research. 74(19_Supplement). 3007–3007. 1 indexed citations
8.
Holzer, Timothy R., Beverly L. Falcón, Angie D. Fulford, et al.. (2014). Abstract 3004: VEGFR2 expression and vascular phenotyping demonstrate different patterns of tumor angiogenesis in human gastric and breast cancers. Cancer Research. 74(19_Supplement). 3004–3004. 1 indexed citations
9.
Holzer, Timothy R., Angie D. Fulford, Rebecca R. Hozak, et al.. (2013). Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung. PLoS ONE. 8(11). e80292–e80292. 39 indexed citations
10.
Jones, RoseMarie, Brenda Cacucci, David Castro‐Díaz, et al.. (2011). Vitamin D and Hyperparathyroidism in Obesity. The Journal of Clinical Endocrinology & Metabolism. 96(5). 1320–1326. 94 indexed citations
11.
Holzer, Timothy R., et al.. (2011). Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks.. PubMed. 31(6). 2073–81. 27 indexed citations
12.
Cassady, Bridget A., James Hollis, Angie D. Fulford, Robert V. Considine, & Richard D. Mattes. (2009). Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response. American Journal of Clinical Nutrition. 89(3). 794–800. 193 indexed citations
13.
Fulford, Angie D., et al.. (2009). Serum Markers of Bone Turnover Are Increased at Six and 18 Months after Roux-En-Y Bariatric Surgery: Correlation with the Reduction in Leptin. The Journal of Clinical Endocrinology & Metabolism. 95(1). 159–166. 98 indexed citations
14.
Lteif, Amale, et al.. (2008). Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans. American Journal of Physiology-Endocrinology and Metabolism. 295(6). E1510–E1517. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026